← FDA Drug Approvals (Drugs@FDA)

LYMPHIR

BLA · Biologics License Application · Sponsor: CITIUS PHARMS · Approved 2024-08-07

Drug application

FDA Application #

BLA761312

Application type

Biologics License Application

Brand name

LYMPHIR

Generic name

DENILEUKIN DIFTITOX-CXDL

Active ingredients

DENILEUKIN DIFTITOX-CXDL

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

CITIUS PHARMS

Manufacturer

Citius Pharmaceuticals, Inc.

First approval

2024-08-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown